Cargando…

Exploring Neurofilament Light Chain and Exosomes in the Genetic Forms of Frontotemporal Dementia

Differential diagnosis of neurological disorders and their subtype classification are challenging without specific biomarkers. Genetic forms of these disorders, typified by an autosomal dominant family history, could offer a window to identify potential biomarkers by exploring the presymptomatic sta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zanardini, Roberta, Saraceno, Claudia, Benussi, Luisa, Squitti, Rosanna, Ghidoni, Roberta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821515/ https://www.ncbi.nlm.nih.gov/pubmed/35145377 http://dx.doi.org/10.3389/fnins.2022.758182

Ejemplares similares

Plasma Extracellular Vesicle Size and Concentration Are Altered in Alzheimer’s Disease, Dementia With Lewy Bodies, and Frontotemporal Dementia
por: Longobardi, Antonio, et al.
Publicado: (2021)

Neurofilament light chain: a biomarker for genetic frontotemporal dementia
por: Meeter, Lieke H., et al.
Publicado: (2016)

Molecular Pathways Bridging Frontotemporal Lobar Degeneration and Psychiatric Disorders
por: Zanardini, Roberta, et al.
Publicado: (2016)

Cerebrospinal Fluid EV Concentration and Size Are Altered in Alzheimer’s Disease and Dementia with Lewy Bodies
por: Longobardi, Antonio, et al.
Publicado: (2022)

Prodromal frontotemporal dementia: clinical features and predictors of progression
por: Benussi, Alberto, et al.
Publicado: (2021)

Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Verde, Federico, et al.
Publicado: (2021)

Plasma Neurofilament Light Chain and Clinical Diagnosis in Frontotemporal Dementia Syndromes
por: Ooi, Suyi, et al.
Publicado: (2022)

Regulatory miRNAs in Cardiovascular and Alzheimer’s Disease: A Focus on Copper
por: Sacco, Anna, et al.
Publicado: (2022)

Genome Wide Association Study and Next Generation Sequencing: A Glimmer of Light Toward New Possible Horizons in Frontotemporal Dementia Research
por: Ciani, Miriam, et al.
Publicado: (2019)

Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia
por: Landqvist Waldö, Maria, et al.
Publicado: (2013)

Increased Serum Beta-Secretase 1 Activity is an Early Marker of Alzheimer’s Disease
por: Nicsanu, Roland, et al.
Publicado: (2022)

Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
por: Rohrer, Jonathan D., et al.
Publicado: (2016)

Clinical Value of Longitudinal Serum Neurofilament Light Chain in Prodromal Genetic Frontotemporal Dementia
por: Giannini, Lucia A.A., et al.
Publicado: (2023)

Plasma Small Extracellular Vesicles with Complement Alterations in GRN/C9orf72 and Sporadic Frontotemporal Lobar Degeneration
por: Bellini, Sonia, et al.
Publicado: (2022)

Toward a Glutamate Hypothesis of Frontotemporal Dementia
por: Benussi, Alberto, et al.
Publicado: (2019)

Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia
por: Zhu, Nuole, et al.
Publicado: (2021)

Urine as matrix for analysis of neurofilament light chain is not suitable to distinguish frontotemporal dementia from psychiatric diseases
por: van Engelen, Marie-Paule E, et al.
Publicado: (2023)

Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia
por: Meeter, Lieke H H, et al.
Publicado: (2019)

Correction: Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia
por: Zhu, Nuole, et al.
Publicado: (2023)

The Missing Heritability of Sporadic Frontotemporal Dementia: New Insights from Rare Variants in Neurodegenerative Candidate Genes
por: Ciani, Miriam, et al.
Publicado: (2019)

Plasma neurofilament light protein correlates with diffusion tensor imaging metrics in frontotemporal dementia
por: Spotorno, Nicola, et al.
Publicado: (2020)

Investigating the Endo-Lysosomal System in Major Neurocognitive Disorders Due to Alzheimer’s Disease, Frontotemporal Lobar Degeneration and Lewy Body Disease: Evidence for SORL1 as a Cross-Disease Gene
por: Benussi, Luisa, et al.
Publicado: (2021)

Pathological 25 kDa C-Terminal Fragments of TDP-43 Are Present in Lymphoblastoid Cell Lines and Extracellular Vesicles from Patients Affected by Frontotemporal Lobar Degeneration and Neuronal Ceroidolipofuscinosis Carrying a GRN Mutation
por: Cimini, Sara, et al.
Publicado: (2022)

The role of neurofilament light in genetic frontotemporal lobar degeneration
por: Zetterberg, Henrik, et al.
Publicado: (2022)

Loss of Neuroprotective Factors in Neurodegenerative Dementias: The End or the Starting Point?
por: Benussi, Luisa, et al.
Publicado: (2017)

Plasma Small Extracellular Vesicle Cathepsin D Dysregulation in GRN/C9orf72 and Sporadic Frontotemporal Lobar Degeneration
por: Bellini, Sonia, et al.
Publicado: (2022)

The diagnostic performance of neurofilament light chain in CSF and blood for Alzheimer's disease, frontotemporal dementia, and amyotrophic lateral sclerosis: A systematic review and meta-analysis
por: Forgrave, Lauren M., et al.
Publicado: (2019)

Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders
por: Katisko, Kasper, et al.
Publicado: (2019)

Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum
por: Meeter, Lieke H.H., et al.
Publicado: (2018)

A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias
por: Bolsewig, Katharina, et al.
Publicado: (2022)

N-Terminally Truncated and Pyroglutamate-Modified Aβ Forms Are Measurable in Human Cerebrospinal Fluid and Are Potential Markers of Disease Progression in Alzheimer’s Disease
por: Domingo, Guido, et al.
Publicado: (2021)

A Novel Neurofilament Light Chain ELISA Validated in Patients with Alzheimer’s Disease, Frontotemporal Dementia, and Subjective Cognitive Decline, and the Evaluation of Candidate Proteins for Immunoassay Calibration
por: Das, Shreyasee, et al.
Publicado: (2022)

The PINK1 p.Asn521Thr Variant Is Associated with Earlier Disease Onset in GRN/C9orf72 Frontotemporal Lobar Degeneration
por: Rossi, Giacomina, et al.
Publicado: (2022)

Novel CSF biomarkers in genetic frontotemporal dementia identified by proteomics
por: van der Ende, Emma L., et al.
Publicado: (2019)

Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration
por: Rojas, Julio C., et al.
Publicado: (2021)

Neurofilament light chain: defining the analyte
por: Leckey, Claire A., et al.
Publicado: (2022)

Elevated Levels of Serum Neurofilament Light Chain Associated with Cognitive Impairment in Vascular Dementia
por: Ma, Weibin, et al.
Publicado: (2020)

Plasma neurofilament light chain is associated with cognitive decline in non-dementia older adults
por: He, Lingxiao, et al.
Publicado: (2021)

Neurofilament light chain predicts future dementia risk in cerebral small vessel disease
por: Egle, Marco, et al.
Publicado: (2021)

Frontotemporal dementia – a catastrophic form of dementia praecox
por: Costa, A. R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_11o98m9n71806hd5hf7b3t6fuf